Privia Health Group (NASDAQ:PRVA) CFO Sells $30,150.00 in Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 1,206 shares of the business’s stock in a transaction on Monday, May 4th. The shares were sold at an average price of $25.00, for a total transaction of $30,150.00. Following the completion of the transaction, the chief financial officer directly owned 214,847 shares of the company’s stock, valued at $5,371,175. This trade represents a 0.56% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

David Mountcastle also recently made the following trade(s):

• On Friday, May 1st, David Mountcastle sold 7,179 shares of Privia Health Group stock. The shares were sold at an average price of $25.03, for a total transaction of $179,690.37.
• On Thursday, April 2nd, David Mountcastle sold 5,566 shares of Privia Health Group stock. The shares were sold at an average price of $20.85, for a total transaction of $116,051.10.
• On Monday, March 16th, David Mountcastle sold 6,391 shares of Privia Health Group stock. The shares were sold at an average price of $22.11, for a total transaction of $141,305.01.
• On Friday, March 13th, David Mountcastle sold 6,565 shares of Privia Health Group stock. The shares were sold at an average price of $21.52, for a total transaction of $141,278.80.
• On Thursday, March 12th, David Mountcastle sold 6,453 shares of Privia Health Group stock. The shares were sold at an average price of $21.90, for a total transaction of $141,320.70.
• On Monday, March 9th, David Mountcastle sold 5,829 shares of Privia Health Group stock. The shares were sold at an average price of $22.84, for a total transaction of $133,134.36.
• On Friday, March 6th, David Mountcastle sold 5,177 shares of Privia Health Group stock. The shares were sold at an average price of $23.15, for a total transaction of $119,847.55.
• On Thursday, February 26th, David Mountcastle sold 5,361 shares of Privia Health Group stock. The shares were sold at an average price of $25.00, for a total transaction of $134,025.00.
• On Friday, February 27th, David Mountcastle sold 7,697 shares of Privia Health Group stock. The shares were sold at an average price of $25.05, for a total transaction of $192,809.85.

Privia Health Group Price Performance

Shares of PRVA stock opened at $23.99 on Friday. The firm has a market capitalization of $3.01 billion, a price-to-earnings ratio of 141.12, a price-to-earnings-growth ratio of 1.50 and a beta of 0.96. Privia Health Group, Inc. has a 12-month low of $18.77 and a 12-month high of $26.51. The firm has a fifty day moving average of $22.73 and a 200-day moving average of $23.34.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.19 EPS for the quarter, beating the consensus estimate of $0.08 by $0.11. The business had revenue of $603.85 million for the quarter, compared to analysts’ expectations of $560.99 million. Privia Health Group had a net margin of 1.08% and a return on equity of 3.06%. The firm’s revenue was up 25.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.22 EPS. Research analysts expect that Privia Health Group, Inc. will post 0.37 earnings per share for the current year.

Key Stories Impacting Privia Health Group

Here are the key news stories impacting Privia Health Group this week:

• Positive Sentiment: Reported Q1 results showed material revenue outperformance (company: $603.9M vs. street ~$561M) and management reiterated FY?2026 revenue guidance (~$2.4B–$2.5B), supporting growth expectations. Privia Health Reports First Quarter 2026 Financial Results
• Neutral Sentiment: Some previews and follow?ups highlight key metrics investors will parse (patient volumes, margin trends, and guidance drivers) rather than create a clear directional read until the conference call details are digestible. What to expect from Privia Health’s (PRVA) Q1 earnings
• Neutral Sentiment: Coverage is mixed on the underlying EPS figure (some outlets cite a beat while others report a miss), creating short?term noise as investors reconcile the company release, third?party estimates and timing/adjustments. Privia Health (PRVA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
• Negative Sentiment: Insider selling from senior executives (CFO sales under a 10b5?1 plan) has been disclosed recently; while pre?arranged plans lessen governance concerns, the transactions can pressure near?term sentiment. Privia Health (PRVA) Insider Selling
• Negative Sentiment: Director share sales (also under 10b5?1 plans) add to the near?term supply narrative and may offset some of the positive reaction to top?line strength. Director Matthew Shawn Morris Sells Shares

Institutional Investors Weigh In On Privia Health Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Wealth Alliance LLC lifted its position in Privia Health Group by 4.4% during the 3rd quarter. Wealth Alliance LLC now owns 11,979 shares of the company’s stock worth $298,000 after buying an additional 508 shares in the last quarter. Arizona State Retirement System lifted its position in Privia Health Group by 1.9% during the 3rd quarter. Arizona State Retirement System now owns 28,835 shares of the company’s stock worth $718,000 after buying an additional 524 shares in the last quarter. Illinois Municipal Retirement Fund lifted its position in Privia Health Group by 1.1% during the 3rd quarter. Illinois Municipal Retirement Fund now owns 55,501 shares of the company’s stock worth $1,382,000 after buying an additional 585 shares in the last quarter. PNC Financial Services Group Inc. lifted its position in Privia Health Group by 9.6% during the 3rd quarter. PNC Financial Services Group Inc. now owns 7,731 shares of the company’s stock worth $193,000 after buying an additional 675 shares in the last quarter. Finally, Truist Financial Corp lifted its position in Privia Health Group by 4.6% during the 3rd quarter. Truist Financial Corp now owns 17,634 shares of the company’s stock worth $439,000 after buying an additional 783 shares in the last quarter. 94.48% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts recently commented on the stock. Truist Financial boosted their price objective on shares of Privia Health Group from $31.00 to $33.00 and gave the company a “buy” rating in a research report on Monday, March 2nd. Royal Bank Of Canada assumed coverage on shares of Privia Health Group in a research report on Friday, January 9th. They issued an “outperform” rating and a $31.00 price objective on the stock. Jefferies Financial Group reaffirmed a “buy” rating and issued a $32.00 price objective on shares of Privia Health Group in a research report on Thursday, February 26th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Privia Health Group in a research report on Friday, March 27th. Finally, Canaccord Genuity Group boosted their price objective on shares of Privia Health Group from $34.00 to $35.00 and gave the company a “buy” rating in a research report on Friday, February 27th. Eleven analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Privia Health Group has a consensus rating of “Moderate Buy” and an average price target of $31.31.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.